Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C and D Bacterin-Toxoid
For use in healthy cattle and sheep as an aid in preventing blackleg caused by Clostridium chauvoei, malignant edema caused by Cl. septicum, bacillary hemoglobinuria caused by Cl. haemolyticum, black disease caused by Cl. novyi, gas gangrene caused by CI. sordellii, and enterotoxemia and enteritis caused by Cl. perfringens Types B, C and D. Although Cl. perfringens Type B is not a significant problem in North America, immunity is provided by the beta toxoid of Type C and the epsilon toxoid of Type D. Ultrabac 8 consists of killed, standardized cultures of Cl. chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, and Cl. perfringens Types C and D, with an adjuvant.
Aids in the prevention of diseases caused by the clostridial agents indicated above.
Helps prevent eight clostridial diseases (including diseases caused by CI. haemolyticum and CI. perfringens Types B, C and D), which continue to be of economic importance in cattle. Clostridium bacteria are universally present and produce potent toxins that can result in rapid death of otherwise healthy animals.
Helps provide comprehensive clostridial protection in one vaccine.
Subcutaneous (SC) dose is 5 mL followed by a second dose given four to six weeks later. Annual revaccination with a single dose is recommended.
For CI. haemolyticum, repeat the dose every 6 months in animals subject to re-exposure.
Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.